Effect of chelators and nisin produced in situ on inhibition and inactivation of gram negatives.
The ability of chelators and nisin generated in situ to inhibit and inactivate E. coli and other gram negatives in a model substrate was investigated. The effect of various chelators and different concentrations of exogenous nisin on inhibition of E. coli in broth medium showed that only EDTA and pyrophosphates were able to cause appreciable inhibition of E. coli by nisin. In a broth where L. lactis NCFB 497 produced nisin in a concentration of 250-300 IU/ml, pyrophosphates were unable to inactivate E. coli. Under the same conditions, addition of EDTA led to inactivation of E. coli at neutral and slightly acidic pH only. A cocktail of strains of E. coli was less sensitive than E. coli ATCC 25922 alone. Pseudomonas aeruginosa was more sensitive and salmonellae more resistant. EDTA also caused a slight reduction in the L. lactis population and its biochemical activity as regards pH drop and acid production. Some of the inhibition of E. coli could be ascribed to the physical presence of Lactococcus cells rather than their metabolites excreted into the medium. Failure to observe any inhibition in fermented broths at their natural pH (4.0) was ascribed to the poor chelating power of EDTA under acid conditions.
Boziaris
I S
IS
School of Biological Sciences, University of Surrey, Guildford, UK.
Adams
M R
MR
D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000494:pharmacology*; D001681:Biological Assay; D002614:Chelating Agents / Q000494:pharmacology*; D019343:Citric Acid / Q000494:pharmacology; D015169:Colony Count, Microbial; D011756:Diphosphates / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000254:growth & development*; D016905:Gram-Negative Bacterial Infections / Q000517:prevention & control*; D006863:Hydrogen-Ion Concentration; D016982:Micrococcus luteus / Q000187:drug effects / Q000254:growth & development; D009561:Nisin / Q000096:biosynthesis / Q000494:pharmacology*; D010710:Phosphates / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D012477:Salmonella enteritidis / Q000187:drug effects / Q000254:growth & development
D000900:Anti-Bacterial Agents; D002614:Chelating Agents; D011756:Diphosphates; D010710:Phosphates; D009561:Nisin; D019343:Citric Acid; D004492:Edetic Acid